Vivani Medical, Inc. (VANI) stock
VANINasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$1.01+0.03 (+2.70%)
Close on Nov 13, 2026Market cap $91.11MP/E –Yield –
Vivani Medical ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Vivani Medical's ebitda for the twelve months ending Mar 31, 2026 was -$27.36M. For fiscal 2025 it was -$27.13M. The highest annual figure on record is -$12.98M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$27.13M | – |
| FY2024 | Dec 31, 2024 | -$24.28M | – |
| FY2023 | Dec 31, 2023 | -$26.61M | – |
| FY2022 | Dec 31, 2022 | -$20.86M | – |
| FY2021 | Dec 31, 2021 | -$12.98M | – |
| FY2020 | Dec 31, 2020 | -$14.73M | – |
| FY2019 | Dec 31, 2019 | -$33.56M | – |
| FY2018 | Dec 31, 2018 | -$34.75M | – |
| FY2017 | Dec 31, 2017 | -$28.15M | – |
| FY2016 | Dec 31, 2016 | -$32.78M | – |
| FY2015 | Dec 31, 2015 | -$19.71M | – |
| FY2014 | Dec 31, 2014 | -$20.95M | – |
| FY2013 | Dec 31, 2013 | -$17.68M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$7.40M | – |
| Q1 FY2026 | Mar 31, 2026 | -$6.69M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.69M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.62M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.36M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.46M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.37M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.20M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.58M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.13M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.12M | – |
| Q3 FY2023 | Sep 30, 2023 | -$7.07M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.92M | – |
| Q1 FY2023 | Mar 31, 2023 | -$6.49M | – |
| Q4 FY2022 | Dec 31, 2022 | -$7.68M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.34M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.00M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.82M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.21M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.26M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.28M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.82M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.26M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.58M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.10M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.80M | – |
| Q4 FY2019 | Dec 31, 2019 | -$8.02M | – |
| Q3 FY2019 | Sep 30, 2019 | -$7.52M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.34M | – |
| Q1 FY2019 | Mar 31, 2019 | -$9.67M | – |
| Q4 FY2018 | Dec 31, 2018 | -$8.77M | – |
| Q3 FY2018 | Sep 30, 2018 | -$8.44M | – |
| Q2 FY2018 | Jun 30, 2018 | -$7.88M | – |
| Q1 FY2018 | Mar 31, 2018 | -$9.66M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.32M | – |
| Q3 FY2017 | Sep 30, 2017 | -$6.63M | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.76M | – |
| Q1 FY2017 | Mar 31, 2017 | -$7.44M | – |
| Q4 FY2016 | Dec 31, 2016 | -$10.26M | – |
See a number that looks wrong?